Kiniksa Pharmaceuticals, Ltd.

KNSA · NASDAQ
Analyze with AI
$41.47+$0.10 (+0.24%)
At close:Dec 17, 2025, 9:00 PM UTC
$41.42−$0.05 (−0.12%)
After hours:Dec 17, 2025, 9:20 PM UTC
P/E TTM84.98
P/B TTM5.7
P/S TTM5.08
Dividend Yield0%
EPS$0.45
Beta0.014
Valuation
PEG Ratio0.12
FCF Yield3.35%
EV / EBITDA66.26
Quality
ROIC4.77%
Gross Margin74.24%
Cash Conv. Ratio2.86
Growth
Revenue 3Y CAGR24.34%
FCF Growth92.94%
Safety
Net Debt / EBITDA-3.81
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00

Kiniksa Pharmaceuticals, Ltd. (KNSA) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Kiniksa Pharmaceuticals, Ltd. (KNSA) stock price today?

As of Dec 17, 2025, 9:00 PM UTC, Kiniksa Pharmaceuticals, Ltd. (KNSA) stock is trading at $41.47. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date KNSA stock quotes for informed trading decisions.

What is Kiniksa Pharmaceuticals, Ltd.'s market capitalization?

Kiniksa Pharmaceuticals, Ltd. (KNSA) has a market capitalization of approximately $3.0B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Kiniksa Pharmaceuticals, Ltd.'s size relative to other companies in the USD market. The market cap figure updates automatically as the KNSA stock price changes.

What is the 52-week range for Kiniksa Pharmaceuticals, Ltd. stock?

Kiniksa Pharmaceuticals, Ltd. (KNSA) stock has traded in a 52-week range of $17.82 — $42.98. The 52-week range shows the highest and lowest prices at which KNSA traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Kiniksa Pharmaceuticals, Ltd. stock price to this range provides context for recent price action.

How much trading volume does Kiniksa Pharmaceuticals, Ltd. stock have?

Kiniksa Pharmaceuticals, Ltd. (KNSA) stock recently traded approximately 381.3K shares. Trading volume indicates market liquidity and investor interest in KNSA. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Kiniksa Pharmaceuticals, Ltd. stock.

Does Kiniksa Pharmaceuticals, Ltd. pay dividends to shareholders?

Yes, Kiniksa Pharmaceuticals, Ltd. (KNSA) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Kiniksa Pharmaceuticals, Ltd. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Kiniksa Pharmaceuticals, Ltd.'s intraday price range?

Today, Kiniksa Pharmaceuticals, Ltd. (KNSA) stock has traded in a range of $41.21 — $42.00. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring KNSA's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Kiniksa Pharmaceuticals, Ltd. stock data?

AlphaPilot sources real-time KNSA stock quotes, fundamental financial data, and historical price charts for Kiniksa Pharmaceuticals, Ltd. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Kiniksa Pharmaceuticals, Ltd. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of KNSA stock performance.